Human steroidogenic factor-1 (hSF-1) regulates progesterone biosynthesis and growth of ovarian surface epithelial cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 119, Issue 1-2, 2010, Pages 14-25

  Ramayya, M S ^a   Sheng, M ^a   Moroz, K ^a   Hill, S M ^a   Rowan, B G ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell proliferation; Estrogen receptor; Ovarian epithelial cancer; Progesterone; Steroidogenic factor 1

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HYDROXYSTEROID DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROGESTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROIDOGENIC FACTOR 1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; DOWN REGULATION; EPITHELIUM CELL; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PROTEIN EXPRESSION;

APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PHOSPHOPROTEINS; PROGESTERONE; PROGESTERONE REDUCTASE; STEROIDOGENIC FACTOR 1;

EID: 76749118445     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.11.006     Document Type: Article

References (61)

1. Ozols R.F. Treatment goals in ovarian cancer. Int. J. Gynecol. Cancer 1 15 Suppl. (2005) 3-11
2. Aletti G.D., Gallenberg M.M., Cliby W.A., Jatoi A., and Hartmann L.C. Current management strategies for ovarian cancer. Mayo Clin. Proc. 82 6 (2007) 751-770
3. Lukanova A., and Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol. Biomarkers Prev. 14 1 (2005) 98-107
4. Okamura H., Katabuchi H., and Ohba T. What we have learned from isolated cells from human ovary?. Mol. Cell. Endocrinol. 202 1-2 (2003) 37-45
5. Suga S., Kato K., Ohgami T., Yamayoshi A., Adachi S., Asanoma K., Yamaguchi S., Arima T., Kinoshita K., and Wake N. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol. Oncol. 105 2 (2007) 341-350
6. Wong A.S., and Leung P.C. Role of endocrine and growth factors on the ovarian surface epithelium. J. Obstet. Gynaecol. Res. 33 1 (2007) 3-16
7. Lala D.S., Ikeda Y., Luo X., Baity L.A., Meade J.C., and Parker K.L. A cell-specific nuclear receptor regulates the steroid hydroxylases. Steroids 60 1 (1995) 10-14
8. Morohashi K., Zanger U.M., Honda S., Hara M., Waterman M.R., and Omura T. Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol. Endocrinol. 7 9 (1993) 1196-1204
9. Parker K.L., Rice D.A., Lala D.S., Ikeda Y., Luo X., Wong M., Bakke M., Zhao L., Frigeri C., Hanley N.A., Stallings N., and Schimmer B.P. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 57 (2002) 19-36
10. Michael M.D., Kilgore M.W., Morohashi K., and Simpson E.R. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J. Biol. Chem. 270 22 (1995) 13561-13566
11. Mendelson C.R., Jiang B., Shelton J.M., Richardson J.A., and Hinshelwood M.M. Transcriptional regulation of aromatase in placenta and ovary. J. Steroid Biochem. Mol. Biol. 95 1-5 (2005) 25-33
12. Sugawara T., Holt J.A., Kiriakidou M., and Strauss III J.F. Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene. Biochemistry 35 28 (1996) 9052-9059
13. Fujieda K., Tajima T., Nakae J., Sageshima S., Tachibana K., Suwa S., Sugawara T., and Strauss III J.F. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J. Clin. Invest. 99 6 (1997) 1265-1271
14. Wong M., Ramayya M.S., Chrousos G.P., Driggers P.H., and Parker K.L. Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J. Mol. Endocrinol. 17 2 (1996) 139-147
15. Ramayya M.S., Zhou J., Kino T., Segars J.H., Bondy C.A., and Chrousos G.P. Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J. Clin. Endocrinol. Metab. 82 6 (1997) 1799-1806
16. Morohashi K., Hatano O., Nomura M., Takayama K., Hara M., Yoshii H., Takakusu A., and Omura T. Function and distribution of a steroidogenic cell-specific transcription factor, Ad4BP. J. Steroid Biochem. Mol. Biol. 53 1-6 (1995) 81-88
17. Sasano H., Kaga K., Sato S., Yajima A., and Nagura H. Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary. Hum. Pathol. 27 6 (1996) 595-598
18. Takayama K., Sasano H., Fukaya T., Morohashi K., Suzuki T., Tamura M., Costa M.J., and Yajima A. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J. Clin. Endocrinol. Metab. 80 9 (1995) 2815-2821
19. Abd-Elaziz M., Moriya T., Akahira J., Suzuki T., and Sasano H. StAR and progesterone producing enzymes (3beta-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: immunohistochemical and real-time PCR studies. Cancer Sci. 96 4 (2005) 232-239
20. Shridhar V., Lee J., Pandita A., Iturria S., Avula R., Staub J., Morrissey M., Calhoun E., Sen A., Kalli K., Keeney G., Roche P., Cliby W., Lu K., Schmandt R., Mills G.B., Bast Jr. R.C., James C.D., Couch F.J., Hartmann L.C., Lillie J., and Smith D.I. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 61 15 (2001) 5895-5904
21. Rae M.T., Niven D., Ross A., Forster T., Lathe R., Critchley H.O.D., Ghazal P., and Hillier S.G. Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1alpha determined by microarray analysis. J. Endocrinol. 183 1 (2004) 19-28
22. Ivarsson K., Sundfeldt K., Brannstrom M., and Janson P.O. Production of steroids by human ovarian surface epithelial cells in culture: possible role of progesterone as growth inhibitor. Gynecol. Oncol. 82 1 (2001) 116-121
23. Taube M., Hockenstrom T., Isaksson M., Lindgren P.R., and Backstrom T. Low sex steroid environment affects survival and steroid secretion of ovarian tumour cells in primary cultures. Int. J. Oncol. 20 3 (2002) 589-594
24. Wimalasena J., Meehan D., and Cavallo C. Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins. Gynecol. Oncol. 41 1 (1991) 56-63
25. Cunat S., Hoffmann P., and Pujol P. Estrogens and epithelial ovarian cancer. Gynecol. Oncol. 94 1 (2004) 25-32
26. Ho S.M. Estrogen, progesterone and epithelial ovarian cancer. Reprod. Biol. Endocrinol. 1 (2003) 73
27. Hinkula M., Pukkala E., Kyyronen P., and Kauppila A. Incidence of ovarian cancer of grand multiparous women-a population-based study in Finland. Gynecol. Oncol. 103 1 (2006) 207-211
28. Syed V., Ulinski G., Mok S.C., Yiu G.K., and Ho S.M. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res. 61 18 (2001) 6768-6776
29. Li L.A., Chang Y.C., Wang C.J., Tsai F.Y., Jong S.B., and Chung B.C. Steroidogenic factor 1 differentially regulates basal and inducible steroidogenic gene expression and steroid synthesis in human adrenocortical H295R cells. J. Steroid Biochem. Mol. Biol. 91 1-2 (2004) 11-20
30. Ito M., Achermann J.C., and Jameson J.L. A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. J. Biol. Chem. 275 41 (2000) 31708-31714
31. Gentry M., Taormina J., Pyles R.B., Yeager L., Kirtley M., Popov V.L., Klimpel G., and Eaves-Pyles T. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection. Infect. Immun. 75 8 (2007) 3969-3978
32. Schmittgen T.D., and Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3 6 (2008) 1101-1108
33. Sugawara T., Kiriakidou M., McAllister J.M., Holt J.A., Arakane F., and Strauss III J.F. Regulation of expression of the steroidogenic acute regulatory protein (StAR) gene: a central role for steroidogenic factor 1. Steroids 62 1 (1997) 5-9 (published erratum appears in Steroids 1997 Apr;62(4):395)
34. Sato Y., Suzuki T., Hidaka K., Sato H., Ito K., Ito S., and Sasano H. Immunolocalization of nuclear transcription factors, DAX-1 and COUP-TF II, in the normal human ovary: correlation with adrenal 4 binding protein/steroidogenic factor-1 immunolocalization during the menstrual cycle. J. Clin. Endocrinol. Metab. 88 7 (2003) 3415-3420
35. Jo Y., and Stocco D.M. Regulation of steroidogenesis and steroidogenic acute regulatory protein in R2C cells by DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene-1). Endocrinology 145 12 (2004) 5629-5637
36. Sandhoff T.W., and McLean M.P. Repression of the rat steroidogenic acute regulatory (StAR) protein gene by PGF2alpha is modulated by the negative transcription factor DAX-1. Endocrine 10 1 (1999) 83-91
37. Zazopoulos E., Lalli E., Stocco D.M., and Sassone-Corsi P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390 6657 (1997) 311-315
38. Abd-Elaziz M., Akahira J., Moriya T., Suzuki T., Yaegashi N., and Sasano H. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome. Cancer Sci. 94 11 (2003) 980-985
39. Abd-Elaziz M., Moriya T., Akahira J., Nakamura Y., Suzuki T., and Sasano H. Immunolocalization of nuclear transcription factors, DAX-1 and Ad4BP/SF-1, in human common epithelial ovarian tumors: correlations with StAR and steroidogenic enzymes in epithelial ovarian carcinoma. Int. J. Gynecol. Pathol. 24 2 (2005) 153-163
40. Lee P., Rosen D.G., Zhu C., Silva E.G., and Liu J. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. Gynecol. Oncol. 96 3 (2005) 671-677
41. Resta L., Russo S., Colucci G.A., and Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet. Gynecol. 82 2 (1993) 181-186 (New York 1953)
42. Scully R.E. Pathology of ovarian cancer precursors. J. Cell. Biochem. Suppl. 23 (1995) 208-218
43. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. 90 23 (1998) 1774-1786
44. Feeley K.M., and Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 38 2 (2001) 87-95
45. Okamura H., and Katabuchi H. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital. J. Anat. Embryol. 106 2 Suppl. 2 (2001) 263-276
46. Drapkin R., Crum C.P., and Hecht J.L. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. Hum. Pathol. 35 8 (2004) 1014-1021
47. Okamura H., Katabuchi H., Nitta M., and Ohtake H. Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology. Microsc. Res. Tech. 69 6 (2006) 469-481
48. Zhou H., Luo M.P., Schönthal A.H., Pike M.C., Stallcup M.R., Blumenthal M., Zheng W., and Dubeau L. Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity. Cancer Biol. Ther. 1 3 (2002) 300-306
49. Nash D.M., Hess S.A., White B.A., and Peluso J.J. Steroidogenic factor-1 regulates the rate of proliferation of normal and neoplastic rat ovarian surface epithelial cells in vitro. Endocrinology 139 11 (1998) 4663-4671
50. Kommoss F., Pfisterer J., Thome M., Schafer W., Sauerbrei W., and Pfleiderer A. Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects. Gynecol. Oncol. 47 3 (1992) 317-322
51. Lau K.M., Mok S.C., and Ho S.M. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 96 10 (1999) 5722-5727
52. Li A.J., Baldwin R.L., and Karlan B.Y. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am. J. Obstet. Gynecol. 189 1 (2003) 22-27
53. Munstedt K., Steen J., Knauf A.G., Buch T., von Georgi R., and Franke F.E. Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 89 8 (2000) 1783-1791
54. De Sousa Damiao R., Fujiyama Oshima C.T., Stavale J.N., and Goncalves W.J. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries. Oncol. Rep. 18 1 (2007) 25-32
55. Yang X.Y., Xi M.R., Yang K.X., and Yu H. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients. Gynecol. Oncol. 113 1 (2009) 99-104
56. Leite D.B., Junqueira M.G., de Carvalho C.V., Massad-Costa A.M., Gonçalves W.J., Nicolau S.M., Lopes L.A.F., Baracat E.C., and da Silva I.D.C.G. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer. Steroids 73 6 (2008) 676-680
57. Hua W., Christianson T., Rougeot C., Rochefort H., and Clinton G.M. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J. Steroid Biochem. Mol. Biol. 55 3-4 (1995) 279-289
58. Keith Bechtel M., and Bonavida B. Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase. Gynecol. Oncol. 82 1 (2001) 127-138
59. O'Donnell A.J., Macleod K.G., Burns D.J., Smyth J.F., and Langdon S.P. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr. Relat. Cancer 12 4 (2005) 851-866
60. O'Neill C.F., Hunakova L., and Kelland L.R. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. Chem. Biol. Interact. 123 1 (1999) 11-29
61. Murdoch W.J., Van Kirk E.A., Isaak D.D., and Shen Y. Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts. Gynecol. Oncol. 110 2 (2008) 251-255